United States · FDA National Drug Code directory

Spironolactone and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63629-1071_ce6448da-1da3-42c9-b4bb-928ae9b04e14
Product NDC
63629-1071
Form
TABLET
Composition / generic term
Spironolactone and Hydrochlorothiazide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
19870702
Source listing expiry
20261231

Source-listed ingredients

  • SPIRONOLACTONE — 25 mg/1
  • HYDROCHLOROTHIAZIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE, PLASTIC (63629-1071-1) · 63629-1071-1
  • 60 TABLET in 1 BOTTLE, PLASTIC (63629-1071-2) · 63629-1071-2
  • 1000 TABLET in 1 BOTTLE, PLASTIC (63629-1071-3) · 63629-1071-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →